193070-18-7

Usage

Uses

Used in Hair Dye Industry:
2,3-Pyridinediamine, N3-ethyl-(9CI) is used as a coloring agent in the hair dye industry. It contributes to the coloration process in hair coloring products, providing a range of shades and enhancing the overall appearance of dyed hair.
Used in Corrosion Inhibition:
2,3-Pyridinediamine, N3-ethyl-(9CI) has been studied for its potential role as a corrosion inhibitor. It can be employed to protect metal surfaces from corrosion, extending the lifespan of materials and structures in various industries where metal components are exposed to corrosive environments.
Used in Organic Synthesis:
As a building block for various organic synthesis reactions, 2,3-Pyridinediamine, N3-ethyl-(9CI) is utilized in the production of different organic compounds. Its unique structure allows it to participate in a variety of chemical reactions, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Safety Precautions:
It is important to handle 2,3-Pyridinediamine, N3-ethyl-(9CI) with caution and proper safety measures. 2,3-Pyridinediamine,N3-ethyl-(9CI) can be harmful if ingested or inhaled and may cause skin and eye irritation. Adequate protective equipment and handling procedures should be followed to minimize the risk of exposure and ensure the safety of individuals working with this chemical.

Upstream product

• 54231-35-5 3-fuoro-2-nitropyridine 
• 438554-16-6 N-ethyl-2-nitropyridin-3-amine 
• 452-58-4 2,3-Diaminopyridine 
• 108655-59-0 N-(2-aminopyridin-3-yl)acetamide 

Relevant academic research and scientific papers

HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY

The invention relates to chemical compounds of formula (I), (Ia) and (Ib) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man.

Benzimidazole and pyridylimidazole derivatives

This invention relates to benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula I The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Novel processes for preparing compounds of Formula I are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula I in combination with one or more other CNS agents to potentiate the effects of the other CNS agents. Additionally this invention relates to the use such compounds as probes for the localization of GABAA receptors in tissue sections.

Electron deficient flavin as catalyst for baeyer-villiger reaction: Oxidation of cyclobutanones to γ-lactones using hydrogen peroxide

The use of an electron deficient isoalloxazine derivative as coenzyme model for the Baeyer-Villiger oxidation is described. This allows, in the presence of hydrogen peroxide, the catalytic oxidation of cyclobutanones into the corresponding γ-lactones with good to excellent yields.